General Pension Society PZU Joint Stock’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

General Pension Society PZU Joint Stock’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-163,107	Closed	-$13.6M	–	20
2024 Q4	$13.6M	Hold	163,107	–	–	4.18%	10
2024 Q3	$11.9M	Sell	163,107 -51,167	-24%	-$3.85M	3.46%	11
2024 Q2	$14.7M	Buy	214,274 +6,000	+3%	+$416K	4.09%	9
2024 Q1	$14.4M	Buy	208,274 +4,000	+2%	+$275K	4.04%	9
2023 Q4	$14.6M	Hold	204,274	–	–	4.67%	9
2023 Q3	$10.6M	Sell	204,274 -21,000	-9%	-$1.22M	3.79%	11
2023 Q2	$14.3M	Sell	225,274 -21,946	-9%	-$1.37M	5.03%	9
2023 Q1	$13.4M	Hold	247,220	–	–	5.07%	11
2022 Q4	$13.1M	Hold	247,220	–	–	5.71%	9
2022 Q3	$11.5M	Hold	247,220	–	–	5.66%	10
2022 Q2	$14.1M	Sell	247,220 -13,592	-5%	-$771K	6.3%	5
2022 Q1	$16M	Sell	260,812 -21,257	-8%	-$1.1M	5.53%	9
2021 Q4	$14.8M	Hold	282,069	–	–	4.6%	10
2021 Q3	$10.5M	Buy	282,069 +267,119	+1,787%	+$9.29M	3.35%	14
2021 Q2	$610K	Buy	+14,950	New	+$553K	0.19%	18

Other funds holding ITCI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

General Pension Society PZU Joint Stock's ITCI Position: Q1 2025 in Review

General Pension Society PZU Joint Stock sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 163,107 shares — an estimated $13.6M sold.

General Pension Society PZU Joint Stock first reported a position in ITCI in Q2 2021 and held it in 15 quarters. The position peaked at $16M in Q1 2022. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

General Pension Society PZU Joint Stock reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
General Pension Society PZU Joint Stock sold 163,107 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $13.6M.
General Pension Society PZU Joint Stock first reported a position in Intra-Cellular Therapies Inc. in Q2 2021 and held it in 15 quarters.
General Pension Society PZU Joint Stock's Intra-Cellular Therapies Inc. position peaked at $16M in Q1 2022.
395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on General Pension Society PZU Joint Stock's 13F filing for Q1 2025, filed 9 Apr 2025.